Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05338242 · ClinicalTrials.gov registry record · NA

Monitoring Environmental Exposures and Behavioral Change

A NA study of Environmental Exposure and Risk Reduction, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05338242: Completed NA study of Environmental Exposure and Risk Reduction, sponsored by University of Utah.

NCT05338242 is a NA study of Environmental Exposure and Risk Reduction that has completed, run by University of Utah. The registered enrollment target is 30 participants, below the 288-participant average among 13 other Environmental Exposure trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05338242, a NA study of Environmental Exposure and Risk Reduction, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to examine what effect real-time feedback on particulate matter (PM) air pollution levels has on risk recognition and behavior. The hypothesis is that real-time exposure feedback will change perceptions of risk and increase behaviors that avoid exposure to environmental risks. At least one representative household member in participating households will complete a questionnaire to fully understand environmental concerns, risk perceptions, and related behaviors. Half of the households will have PM monitors that continuously display real-time concentrations and an indication of the hazard level. The other participants will have the same device but it will only display the date and time. All participants will then be surveyed again: (a) immediately after sampling is complete (i.e., when the devices are removed from the home), (b) after 3 months and, (c) after 6 months. The goal of repeated surveys is to determine changing understanding of risks, how participating in research and/or receiving real-time exposure data may have changed participant behavior, and what concerns they continue to have. The questionnaire will include questions with categorical and/or quantitative answers (e.g., frequency of specific behaviors) so that changes in risk perception and behavior can be effectively analyzed.

Primary Outcome

Outcomes will be measured by units on a scale that describe how often (frequency) behaviors related to reduction in particulate matter exposure occur. Four (4) behaviors were evaluated for frequency of daily (score=1), weekly (score=2), monthly (score=3), yearly (score=4), never (score=5), and not applicable (score=0). These were summed for a final score. The possible score range was from 0 (none of the behaviors were applicable) to 20 (none of the behaviors were ever done). For example, if all

Interventions

  • DEVICE Real-Time Exposure Feedback

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-07-28
Est. Completion 2024-03-25
Phase NA
University of Utah

818 total trials

What the finished NCT05338242 record still lists

NCT05338242 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 288-participant average among 13 other Environmental Exposure trials with a reported enrollment target (90% lower).

The record links to 3 conditions, with Environmental Exposure appearing as the primary indexed condition, and to 1 intervention - of which Real-Time Exposure Feedback is the first listed.

NCT05338242 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT05338242 about?

NCT05338242 is a clinical study titled "Monitoring Environmental Exposures and Behavioral Change". The goal of this study is to examine what effect real-time feedback on particulate matter (PM) air pollution levels has on risk recognition and behavior. The hypothesis is that real-time exposure feedback will change perceptions of risk and increase behaviors that avoid exposure to environmental ris...

What is the current status of trial NCT05338242?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-07-28. Estimated completion is 2024-03-25.

What conditions does trial NCT05338242 study?

This clinical trial studies the following conditions: Environmental Exposure, Risk Reduction, Risk Behavior, Health.

What interventions are being tested in trial NCT05338242?

The interventions under investigation include: Real-Time Exposure Feedback (DEVICE).

Who is sponsoring clinical trial NCT05338242?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05338242 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Environmental Exposure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05338242's enrollment target sits among peer trials

30 7th of 13 higher than 7 of 13 other Environmental Exposure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Environmental Exposure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05338242, the US trial registry maintained by the National Library of Medicine. NCT05338242 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.